Introduction
Diabetes-related elevated blood sugar is the cause of diabetic retinopathy. Blood sugar excess over time can cause damage to the retina, which is responsible for detecting light and transmitting messages to the brain via the optic nerve, a nerve located in the back of the eye. All over the body, blood arteries are harmed by diabetes. The blood sugar alters the small blood vessels that supply the retina, which is the first step towards eye damage. These alterations result in obstructed blood arteries that leak fluid or bleed because they make it more difficult for blood to circulate. The eyes then develop new, poorly functioning blood vessels to compensate for these clogged blood vessels.
What Is Diabetic Retinopathy?
A condition that affects the retina is called diabetes-related retinopathy. Diabetes can affect anyone at any time. If left untreated, diabetes-related retinopathy can result in blindness or vision loss. However, with the right treatment, visual loss can be avoided, and the progression of the disease can be stopped. There are two forms of retinopathy associated with diabetes:
-
People With Nonproliferative Diabetes-Related Retinopathy (NPDR): Have leaky blood vessels in their retinas during this early stage of the disease. This shows up as either fat, fluid, or hemorrhage in the retina. These blood arteries eventually shut down, leading to ischemia or insufficient blood flow.
-
Proliferative Diabetes-Related Retinopathy: As the condition worsens, aberrant blood vessels enlarge to compensate for the ischemia. These aberrant blood vessels have the potential to bleed blood into the vitreous, the gel-like fluid that fills the eyes, causing tractional changes to the retina's surface, in the end, leading the retina to become detached and cause serious vision loss.
Who Might Get Diabetes-Related Retinopathy?
Diabetic retinopathy may occur in anyone with diabetes, including those with:
-
Type 1 diabetes.
-
Type 2 diabetes.
-
Gestational diabetes. (diabetes during pregnancy).
The following are risk factors for diabetes-related retinopathy if one has diabetes:
-
Pregnancy.
-
Elevated blood pressure.
-
Blood sugar is out of control.
-
Hyperlipidaemia (excess of lipids in the blood).
-
The length of time that one has experienced retinopathy associated with diabetes.
What Mechanisms Implicated in the Pathogenesis of Diabetic Retinopathy?
The pathophysiology of diabetic retinopathy is initiated by hyperglycemia (increased blood sugar); however, evidence indicates that oxidative stress and inflammatory alterations in the retina are important steps in the pathogenesis of hyperglycemia-induced retinopathy. Recent findings indicate that the pathogenesis of diabetic retinopathy is initiated and aided by proinflammatory lipids, insulin dysregulation, epigenetic and epigenomic changes, and beta cellulin signaling that independently initiate and contribute to the pathogenesis of diabetic retinopathy, even in the absence of hyperglycemia.
-
Hyperglycemia and the Regulation of Metabolic Pathways: Chronic hyperglycemia damages tissues and is the primary factor contributing to the onset and advancement of diabetic foot problems. Individual sensitivity to those effects, however, may vary depending on genetics, and other clinical variables such as pregnancy, hypertension, and dyslipidemia have also been linked. Alternative routes of glucose metabolism, including the polyol pathway, the production of advanced glycation end products (AGEs), the activation of protein kinase C (PKC), the flow of the hexosamine pathway, and the activation of poly(ADP-ribose) polymerase, are all triggered by hyperglycemia. These pathways ultimately lead to the activation of growth factors and cytokines, which in turn cause increased vascular permeability, microvascular occlusion, and malfunction of the vessel's endothelium. After microvascular blockage, retinal ischemia occurs, which encourages neovascularization and the development of IRMAs.
-
The Polyol Pathway: Utilizing the polyol pathway, excess glucose is converted to sorbitol. As sorbitol builds up inside cells, it causes osmotic damage because it is impermeable to cell membranes. It can also undergo metabolism to fructose, which then forms AGEs by producing fructose-3-phosphate and deoxyglucosone, two potent glycolysis agents. Affected cells become more vulnerable to oxidative stress due to decreased NADPH availability by activating the polyol pathway.
-
Oxidative Stress: Hyperglycemia in many tissues can change several signaling pathways and lead to oxidative damage. Hyperglycemia activates a specific mechanism involving diacylglycerol (DAG), protein kinase C (PKC), and the NADPH-oxidase system. This specific signaling pathway regulates cell death, oxidative stress, and angiogenesis.
-
Inflammation: Although the precise molecular mechanisms underlying the pathophysiology of diabetes-related retinopathy remain unclear, a growing body of research suggests that inflammation plays a significant role in the disease. The inflammatory response is probably caused by the concurrent activity of several metabolic pathways, including oxidative stress, AGEs, and elevated VEGF expression. Chronic low-grade inflammation is a major cause of capillary blockage and hypoxia, which in turn promotes VEGF production and the corresponding characteristic vascular abnormalities of diabetes.
-
Vascular Abnormalities and Angiogenesis Pathways: The loss of pericytes, endothelial cell death, and thickening of the basement membrane brought on by hyperglycemia all contribute to the BRB's (blood-retinal barrier) dysfunction. Loss of pericytes causes the formation of microaneurysms because they are essential for capillary structural stability. Furthermore, ischemia and capillary blockage are caused by a substantial loss of endothelial cells and pericytes. When retinal ischemia or hypoxia occurs, hypoxia-inducible factor 1 (HIF-1) is activated, which increases VEGF.
-
Retinal Neurodegeneration: The pathophysiology of diabetic retinopathy also affects neural retina cells. Retinal neurodegeneration occurs early in diabetic retinopathy and may even come before vascular apoptosis. Pro-apoptotic molecules are upregulated in the retinal neurons of both human and animal diabetics. These pathways appear to be activated in response to oxidative stress. Retinal degeneration is linked to mitochondrial dysfunction as pro-apoptotic mitochondrial proteins such as cytochrome c, and apoptosis-inducing factor (AIF) were also significantly elevated.
Conclusion
The most frequent consequence of diabetes mellitus is diabetic retinopathy. It has long been identified as a microvascular illness. Microvascular lesions must be found to diagnose diabetic retinopathy. Diabetic retinopathy is still difficult to treat. Diabetic retinopathy patients benefited greatly from the introduction of anti-vascular endothelial growth factor (VEGF) therapy; nonetheless, most patients did not have a statistically meaningful improvement in their visual acuity.
